Correlation Between Memscap Regpt and Innate Pharma

Can any of the company-specific risk be diversified away by investing in both Memscap Regpt and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memscap Regpt and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Memscap Regpt and Innate Pharma, you can compare the effects of market volatilities on Memscap Regpt and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memscap Regpt with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memscap Regpt and Innate Pharma.

Diversification Opportunities for Memscap Regpt and Innate Pharma

0.75

Correlation Coefficient

Memscap Regpt  Innate Pharma

Poor diversification

The 3 months correlation between Memscap and Innate is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Memscap Regpt and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Memscap Regpt is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memscap Regpt are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Memscap Regpt i.e., Memscap Regpt and Innate Pharma go up and down completely randomly.

Pair Corralation between Memscap Regpt and Innate Pharma

Assuming the 90 days trading horizon Memscap Regpt is expected to generate 0.75 times more return on investment than Innate Pharma. However, Memscap Regpt is 1.33 times less risky than Innate Pharma. It trades about 0.39 of its potential returns per unit of risk. Innate Pharma is currently generating about 0.24 per unit of risk. If you would invest  340.00  in Memscap Regpt on October 5, 2024 and sell it today you would earn a total of  164.00  from holding Memscap Regpt or generate 48.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Memscap Regpt  vs.  Innate Pharma

Memscap Regpt

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Memscap Regpt are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Memscap Regpt sustained solid returns over the last few months and may actually be approaching a breakup point.

Innate Pharma

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Innate Pharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong technical indicators, Innate Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Memscap Regpt and Innate Pharma

The main advantage of trading using opposite Memscap Regpt and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memscap Regpt position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.

The idea behind Memscap Regpt and Innate Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.